Safety, Immunogenicity of a Novel HPBCD-Adjuvanted Influenza Vaccine
A novel quadrivalent seasonal influenza vaccine (FluCyd-vac) adjuvanted with hydroxypropropyl-b-cyclodextrin (HP-β-CD) was found to be safe and immunogenic despite containing
Tag: Vaccine
Comparative evaluation of HPBCD-adjuvanted booster vaccine
Background: Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are
Spike Ferritin Nanoparticle Covid-19 vaccine
The US Army has recently developed a SARS-CoV-2 sub-unit vaccine based on a ferritin nanoparticle platform that displays a pre-fusion
HPBCD in vaccine development
Pharmaceutical Technology has published an evaluation from experts on vaccine development. According to recent market research, the vaccines market is
Cyclodextrin-aided veterinary brucellosis vaccine
Shchelkovo biocombinat in Russia producing over 1 billion vaccines annually for ruminants, swine, poultry, pets and horses has recently filed
Cyclodextrins in Antiviral Therapeutics and Vaccines
The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
As we reported on CDN blog FDA approval for Janssen vaccine containing HPBCD was expected in late February. The Janssen
HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
Pfizer and BioNTech announced vaccine candidate against covid-19 achieved success in first interim analysis from Phase 3 study
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer and BioNTech announced on 09 October their mRNA-based vaccine
Nasal administration of COVID-19 vaccine
Researchers lead by Professor Michael S. Diamond at Washington University School of Medicine in St. Louis, have developed a COVID-19